About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Washington | 1,247 Studies

Clinical Trials Breast CancerWashington

Breast Cancer Clinical Trials in Washington

Find 1,247 clinical trials for breast cancer near Washington. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Washington

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1201-1220 of 1,247 trials

UnknownCanady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor SitesThe study designed is to evaluate the safety of Canady Helios™ Cold Plasma Scalpel (CHCPS) in patients with solid tumors with carcinomatosis scheduled to undergo surgical…NCT04267575·Washington D.C., District of Columbia RecruitingA Study With NKT5097 for Adults With Advanced/Metastatic Solid TumorsThe goal of this open-label dose escalation and expansion study is to evaluate the safety and tolerability of NKT5097 in adults with advanced/metastatic tumors (emphasis on breast…NCT07029399·Duarte, California and 17 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedChemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Solid TumorsRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00003899·Seattle, Washington

RecruitingPalazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast CancerThis phase 3 clinical trial compares the efficacy and safety of palazestrant with ribociclib to letrozole and ribociclib in women and men who have not received prior systemic…NCT07085767·Hot Springs, Arkansas and 199 others

CompletedAdjuvant Paclitaxel and Trastuzumab for Node-Negative HER2-Positive Breast CancerThe purpose of this study is to find out what effect the postoperative combination of therapies: trastuzumab (herceptin) and paclitaxel (taxol) will have on breast cancer…NCT00542451·San Francisco, California and 19 others

TerminatedA Study of PF-07260437 in Advanced or Metastatic Solid TumorsA study to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and antitumor activity of PF-07260437, a B7-H4 x CD3 bispecific mAb, in participants…NCT05067972·Duarte, California and 14 others

UnknownNSABP Biospecimen Discovery ProjectThis study is a biospecimen discovery project that will serve as a pilot for a comprehensive 'omics approach using fresh core biopsy tissue and blood samples for DNA and protein…NCT01850628·Gainesville, Florida and 4 others

Active not recruitingTailored Axillary Surgery With or Without Axillary Lymph Node Dissection Followed by Radiotherapy in Patients With Clinically Node-positive Breast Cancer (TAXIS)RATIONALE: The use of tailored axillary dissection as a tailored procedure will avoid surgical overtreatment by selectively removing the lymph nodes that are affected by the…NCT03513614·Bethesda, Maryland and 63 others

RecruitingA Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of RecurrenceThe primary goal of this study is to evaluate the effectiveness of elacestrant versus standard endocrine therapy in participants with node-positive, Estrogen Receptor-positive…NCT06492616·Daphne, Alabama and 566 others

UnknownA Registry Study of Breast Microseed TreatmentFor women diagnosed with early stage breast cancer, lumpectomy followed by radiation is a common treatment option.NCT02701244·Pittsburgh, Pennsylvania and 2 others

Not yet recruitingSignature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Breast CancerThe purpose of this research study is to test a new process for diagnosing breast cancer by examining changes to your DNA that can be detected from a blood test.NCT07374796·Glen Burnie, Maryland

CompletedVitamin D Deficiency, Muscle Pain, Joint Pain, and Joint Stiffness in Postmenopausal Women Receiving Letrozole For Stage I-III Breast CancerThis phase II trial is studying vitamin D deficiency, muscle pain, joint pain, and joint stiffness in postmenopausal women receiving letrozole for stage I-III breast cancer.NCT00416715·Seattle, Washington

RecruitingASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast CancerThe Substudy Protocol ASPEN-09-03 is a Phase 2, single-arm, multicenter study evaluating the efficacy, safety, and tolerability of evorpacept in combination with trastuzumab and…NCT07007559·Phoenix, Arizona and 59 others

RecruitingA Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF AlterationsThe objective of this Master Protocol is to evaluate the efficacy and safety of plixorafenib in participants with BRAF altered (BRAF V600E or BRAF fusions) locally advanced or…NCT05503797·Beverly Hills, California and 69 others

CompletedTrial of ZW25 (Zanidatamab) in Patients With Advanced HER2-expressing CancersThis is a first-in-human, 3-part study to investigate the safety, tolerability, and effectiveness of ZW25 (zanidatamab) by itself and combined with selected chemotherapy agents in…NCT02892123·Birmingham, Alabama and 16 others

CompletedA Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic TumorsThis is a Phase 1a/1b, open-label, multicenter, global, dose-escalation study designed to evaluate the safety, tolerability, immune response, and pharmacokinetics of autogene…NCT03289962·Scottsdale, Arizona and 32 others

CompletedMammoSite as Sole Radiation Therapy Technique for Ductal Carcinoma In-SituThis study has been designed to compile information on the efficacy of the MammoSite RTS providing sole radiation therapy for patients with pure DCIS.NCT00586326·Phoenix, Arizona and 11 others

Active not recruitingTACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study B)The purpose of this clinical trial is to learn about the safety and effects of the study medicine (called ARV-471) when given together with other medicines for the potential…NCT05573555·Palo Alto, California and 28 others

Active not recruitingSecondary BRain Metastases Prevention After Isolated Intracranial Progression on Trastuzumab/Pertuzumab or T-DM1 in Patients With aDvanced Human Epidermal Growth Factor Receptor 2+ brEast Cancer With the Addition of TucatinibPatients with advanced HER2+ breast cancer on maintenance trastuzumab/pertuzumab or T-DM1 with 1st or 2nd intracranial disease event (brain metastases) and stable extracranial…NCT05323955·San Francisco, California and 7 others

Active not recruitingA Comparative Study of AZD9833 Plus Palbociclib Versus Anastrozole Plus Palbociclib in Patients With ER-Positive HER2 Negative Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced DiseaseThe study is intended to show superiority of AZD9833 in combination with palbociclib (a CDK4/6 inhibitor) versus anastrozole (an aromatase inhibitor) and palbociclib as the…NCT04711252·Mobile, Alabama and 262 others

PreviousPage 61 of 63Next

Other Conditions in Washington

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma